UK's NICE backs wider use of BMS, Pfizer anti-clot drug
Reuters: London, Jan 23 2013, 11:33 IST
move, saying it "confirms the value of apixaban as a cost-effective oral anticoagulant".
Previous Story US debt limit vote set for Wed, Barack Obama likely to sign Next Story Bharti Airtel and Idea Cellular raise mobile phone rates
Reader's Comments| Post a Comment
Be the first to comment.